156
Views
13
CrossRef citations to date
0
Altmetric
Articles

Telmisartan Influences the Antiproliferative Activity of Linoleic Acid in Human Colon Cancer Cells

, , , &
Pages 98-109 | Received 14 Nov 2018, Accepted 25 Apr 2019, Published online: 16 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianqing Qiu, Ziyi Zhao, Hongyan Suo, Sarah E. Paraghamian, Gabrielle M. Hawkins, Wenchuan Sun, Xin Zhang, Tianran Hao, Beor Deng, Xiaochang Shen, Chunxiao Zhou & Victoria Bae-Jump. (2024) Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer. Cancer Biology & Therapy 25:1.
Read now

Articles from other publishers (12)

Mukesh Kumar Manickasamy, Sujitha Jayaprakash, Sosmitha Girisa, Aviral Kumar, Hiu Yan Lam, Elena Okina, Huiyan Eng, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi, Alan Prem Kumar & Ajaikumar B. Kunnumakkara. (2024) Delineating the role of nuclear receptors in colorectal cancer, a focused review. Discover Oncology 15:1.
Crossref
Andriana Hadjiyianni & Datis Kalali. (2023) The potential anticancer activities of telmisartan – a literature review. Annales Academiae Medicae Silesiensis 77, pages 176-181.
Crossref
Mayra Montecillo-Aguado, Belen Tirado-Rodriguez & Sara Huerta-Yepez. (2023) The Involvement of Polyunsaturated Fatty Acids in Apoptosis Mechanisms and Their Implications in Cancer. International Journal of Molecular Sciences 24:14, pages 11691.
Crossref
Zühal Bayrakçeken Güven, Osama Alshehri, Neslihan Yüce, Ebubekir Bakan, Betül Demirci, Mustafa Abdullah Yilmaz, Abdulselam Ertas & A.Ahmet Basaran. (2023) Chemical composition, nutritional values, elemental analysis and biological properties of Prunus mahaleb L.: From waste to new potential sources for food, cosmetic and drug industry. Food Bioscience 53, pages 102632.
Crossref
William Mangione, Zackary Falls & Ram Samudrala. (2023) Effective holistic characterization of small molecule effects using heterogeneous biological networks. Frontiers in Pharmacology 14.
Crossref
Oana Budu, Christian Dragos Banciu, Codruta Soica, Daniel Florin Lighezan, Andreea Milan, Alexandra Prodea, Alexandra Mioc, Marius Mioc, Gabriel Mardale & Laurentiu Sima. (2023) Lacticaseibacillus rhamnosus—A Promising Tool for Colorectal Cancer Treatment. Processes 11:3, pages 781.
Crossref
Eduarda Ribeiro, Bárbara Costa, Francisco Vasques-Nóvoa & Nuno Vale. (2023) In Vitro Drug Repurposing: Focus on Vasodilators. Cells 12:4, pages 671.
Crossref
Bo-Bo Zheng, Quan Wang, Yumin Yue, Jiang Li, Xiao-Jun Li & Xin Wang. (2022) Network Pharmacology and Molecular Docking Validation to Reveal the Pharmacological Mechanisms of Kangai Injection against Colorectal Cancer. BioMed Research International 2022, pages 1-11.
Crossref
Marjan Khorsand, Sahar Khajeh, Mahboobeh Eslami, Navid Nezafat, Younes Ghasemi, Vahid Razban & Zohreh Mostafavi‐Pour. (2022) Telmisartan anti‐cancer activities mechanism through targeting N‐cadherin by mimicking ADH‐1 function. Journal of Cellular and Molecular Medicine 26:8, pages 2392-2403.
Crossref
Dagmara Otto-Ślusarczyk, Wojciech Graboń, Magdalena Mielczarek-Puta & Alicja Chrzanowska. (2021) Teriflunomide – The common drug with underestimated oxygen - Dependent anticancer potential. Biochemistry and Biophysics Reports 28, pages 101141.
Crossref
Dagmara Otto-Ślusarczyk, Magdalena Mielczarek-Puta & Wojciech Graboń. (2021) The Real Cytotoxic Effect of Artemisinins on Colon Cancer Cells in a Physiological Cell Culture Setting. How Composition of the Culture Medium Biases Experimental Findings. Pharmaceuticals 14:10, pages 976.
Crossref
Bianka Bojková, Pawel J. Winklewski & Magdalena Wszedybyl-Winklewska. (2020) Dietary Fat and Cancer—Which Is Good, Which Is Bad, and the Body of Evidence. International Journal of Molecular Sciences 21:11, pages 4114.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.